WASHINGTON (AP) — U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by women older than 65. The ...

U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by postmenopausal women up to 65 years old. The ...

Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire disorder (HSDD)—had no dedicated treatment option available to them. But ...

Bodily changes that impact your sex life are extremely common during menopause, so it's no wonder there are so many supplements out there that claim to address dips in libido. This stage of life comes ...

On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved ...

The drug “Addyi” was first approved back in 2015 for pre-menopausal women. Chiefs backup QB Gardner Minshew says what needs to be said about Patrick Mahomes after crushing injury in loss to Chargers ...

Add Yahoo as a preferred source to see more of our stories on Google. Not feeling “in the mood” as much? Studies have shown that more than half of women experience drops in their sex drive following ...

Imagine this: Everything in your relationship is going great. You love your partner and feel more connected than ever. But ...